In line with this, reduced CBF is observed in patients suffering from Alzheimers Disease, which normalizes following treatment with cholinesterase inhibitors (Okonkwo et al. 2014). This evidence concerns the gene BCHE and early-onset autosomal dominant Alzheimer disease.